Clinical Trial Update: Effects of Fatty Acid Supplementation on Substance Dependent Individuals [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of fatty acid supplementation in individuals with substance-related disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Substance-related Disorders

Drugs mentioned

• Fatty acid supplementation

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Substance-related Disorders | Phase 2 | Status: COMPLETED